Protocol of a First-in-human Clinical Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of the Bispecific CD276xCD3 Antibody CC-3 in Patients with Colorectal Cancer (Core_cc-3)
Frontiers in Oncology（2024）
Key words
colorectal cancer,bispecific antibody,CD276,immunotherapy,clinical trial,translational immunology
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined